Detected ·
Apogee Therapeutics
——
Apogee Therapeutics secured $1.3B in royalty and debt financing from Blackstone Life Sciences to advance lead drug candidate zumilokibart through Phase 3 trials and commercialization.
- Website
- www.apogeetherapeutics.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-05-27 12:09:55 UTC
- Signal ID
- dd533f82-d863-43f4-9ca9-6a848eb73adf
As the API returns it
{
"id": "dd533f82-d863-43f4-9ca9-6a848eb73adf",
"created_at": "2026-05-27T12:09:55.536640Z",
"company_name": "Apogee Therapeutics",
"company_website_url": "www.apogeetherapeutics.com",
"company_linkedin_url": "https://www.linkedin.com/company/apogee-therapeutics",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Apogee Therapeutics secured $1.3B in royalty and debt financing from Blackstone Life Sciences to advance lead drug candidate zumilokibart through Phase 3 trials and commercialization.*"
}